Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference
28 déc. 2023 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry
21 déc. 2023 09h00 HE
|
Cytek Biosciences, Inc.
The new Cytek Orion reagent cocktail preparation system simplifies & accelerates laboratory workflow, assures consistent experimental results & saves time.
Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare Conference
14 nov. 2023 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek® Aurora™ CS System Wins BioTech Breakthrough Award for ‘Cell Sorting Product of the Year’
08 nov. 2023 09h00 HE
|
Cytek Biosciences, Inc.
The Cytek® Aurora™ CS system has been selected as the “Cell Sorting Product of the Year” in the third annual BioTech Breakthrough Awards program.
Cytek Biosciences Reports Third Quarter 2023 Financial Results
07 nov. 2023 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial...
Cytek Biosciences to Report Third Quarter 2023 Financial Results on November 7, 2023
19 oct. 2023 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the third...
Cytek® Biosciences Achieves ISO 13485 Certification at Headquarters
27 sept. 2023 09h00 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that it has received EN ISO 13485:2016 Quality...
Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
20 sept. 2023 16h15 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek® Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe
20 sept. 2023 09h00 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, is furthering its mission to advance the next generation of...
Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry
14 sept. 2023 09h00 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Seeking to expand the knowledge base surrounding spectral flow cytometry, Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis...